NM_000376.3:c.583+118A>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000376.3(VDR):c.583+118A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0555 in 1,499,514 control chromosomes in the GnomAD database, including 2,741 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.040 ( 157 hom., cov: 32)
Exomes 𝑓: 0.057 ( 2584 hom. )
Consequence
VDR
NM_000376.3 intron
NM_000376.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.519
Publications
9 publications found
Genes affected
VDR (HGNC:12679): (vitamin D receptor) This gene encodes vitamin D3 receptor, which is a member of the nuclear hormone receptor superfamily of ligand-inducible transcription factors. This receptor also functions as a receptor for the secondary bile acid, lithocholic acid. Downstream targets of vitamin D3 receptor are principally involved in mineral metabolism, though this receptor regulates a variety of other metabolic pathways, such as those involved in immune response and cancer. Mutations in this gene are associated with type II vitamin D-resistant rickets. A single nucleotide polymorphism in the initiation codon results in an alternate translation start site three codons downstream. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Jun 2018]
VDR Gene-Disease associations (from GenCC):
- vitamin D-dependent rickets, type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- vitamin D-dependent rickets, type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 12-47857011-T-A is Benign according to our data. Variant chr12-47857011-T-A is described in ClinVar as Benign. ClinVar VariationId is 1220995.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0583 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0399 AC: 6076AN: 152180Hom.: 157 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6076
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0572 AC: 77110AN: 1347216Hom.: 2584 AF XY: 0.0576 AC XY: 38784AN XY: 673130 show subpopulations
GnomAD4 exome
AF:
AC:
77110
AN:
1347216
Hom.:
AF XY:
AC XY:
38784
AN XY:
673130
show subpopulations
African (AFR)
AF:
AC:
229
AN:
30904
American (AMR)
AF:
AC:
1005
AN:
43356
Ashkenazi Jewish (ASJ)
AF:
AC:
2519
AN:
24266
East Asian (EAS)
AF:
AC:
4
AN:
38322
South Asian (SAS)
AF:
AC:
4194
AN:
81792
European-Finnish (FIN)
AF:
AC:
1299
AN:
50430
Middle Eastern (MID)
AF:
AC:
182
AN:
4006
European-Non Finnish (NFE)
AF:
AC:
64641
AN:
1018108
Other (OTH)
AF:
AC:
3037
AN:
56032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
3526
7051
10577
14102
17628
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2356
4712
7068
9424
11780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0399 AC: 6077AN: 152298Hom.: 157 Cov.: 32 AF XY: 0.0387 AC XY: 2881AN XY: 74470 show subpopulations
GnomAD4 genome
AF:
AC:
6077
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
2881
AN XY:
74470
show subpopulations
African (AFR)
AF:
AC:
438
AN:
41560
American (AMR)
AF:
AC:
535
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
400
AN:
3472
East Asian (EAS)
AF:
AC:
4
AN:
5190
South Asian (SAS)
AF:
AC:
264
AN:
4822
European-Finnish (FIN)
AF:
AC:
252
AN:
10620
Middle Eastern (MID)
AF:
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4071
AN:
68008
Other (OTH)
AF:
AC:
77
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
310
619
929
1238
1548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
71
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Oct 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.